Neurothera Labs Inc.
NTLX.V
TSX
| 12/31/2025 | 09/30/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -3.86M | -- | -2.29M | ||
| Total Depreciation and Amortization | 50.00K | -- | 91.00K | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 1.72M | -- | 204.00K | ||
| Change in Net Operating Assets | 475.00K | -- | 310.00K | ||
| Cash from Operations | -1.61M | -- | -1.69M | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | 710.00K | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -5.00K | ||
| Cash from Investing | 710.00K | -- | -5.00K | ||
| Total Debt Issued | 1.14M | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 1.39M | -- | 1.66M | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 2.53M | -- | 1.66M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -35.00K | ||
| Net Change in Cash | 1.63M | -- | -64.00K | ||